Coherus BioSciences
Coherus BioSciences is a leading global biologics platform company focused on delivering high-quality biosimilar therapeutics that can expand patient access to important, cost-effective medicines and
delivering significant savings to the US Healthcare system. Coherus was founded a decade ago to provide the highest quality biosimilar treatments to patients. We are proud to now be expanding our
legacy—to build on our success with biosimilars and to focus our core strengths on immuno-oncology. For additional information, please visit www.coherus.com.